Filing Details
- Accession Number:
- 0001140361-20-004033
- Form Type:
- 13G Filing
- Publication Date:
- 2020-02-25 17:28:35
- Filed By:
- Nexperia B.v.
- Company:
- Transphorm Inc.
- Filing Date:
- 2020-02-25
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Nexperia B.V | 0 | 4,000,000 | 0 | 4,000,000 | 4,000,000 | 11.4% |
Wingtech Technology Co. Ltd | 0 | 4,000,000 | 0 | 4,000,000 | 4,000,000 | 11.4% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
(Amendment No. 1)*
Transphorm, Inc.
(Name of Issuer)
Common stock, par value $0.0001 per share
(Title of Class of Securities)
None
(CUSIP Number)
February 12, 2020
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ | Rule 13d-1(b) |
☒ | Rule 13d-1(c) |
☐ | Rule 13d-1(d) |
* | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter
the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the Act.
SCHEDULE 13G | |
CUSIP NO. None | Page 2 of 6 |
1 | NAMES OF REPORTING PERSONS | | | |
Nexperia B.V. | | | ||
| | |||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | |||
(a)☐ | ||||
(b)☒ | | | ||
3 | SEC USE ONLY | | | |
| | | ||
| | |||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | |
The Netherlands | | | ||
| | |||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER | | |
0 | | | ||
| | |||
6 | SHARED VOTING POWER | | | |
4,000,000 shares of common stock (See Item 4) | | | ||
| | |||
7 | SOLE DISPOSITIVE POWER | | | |
0 | | | ||
| | |||
8 | SHARED DISPOSITIVE POWER | | | |
4,000,000 shares of common stock (See Item 4) | | | ||
| | |||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | |
4,000,000 shares of Common Stock (See Item 4) | | | ||
| | |||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | | | |
☐ | | | ||
| | |||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | |
11.4%1 (See Item 4) | | | ||
| | |||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | | | |
CO | | | ||
| |
1 The percentage is calculated based upon 35,173,331 shares of the Issuer’s common stock outstanding as of January 31, 2020, as reported in the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on
February 14, 2020.
SCHEDULE 13G | |
CUSIP NO. None | Page 3 of 6 |
1 | NAMES OF REPORTING PERSONS | | | |
Wingtech Technology Co. Ltd. | | | ||
| | |||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | |||
(a)☐ | ||||
(b)☒ | | | ||
3 | SEC USE ONLY | | | |
| | | ||
| | |||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | |
China | | | ||
| | |||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER | | |
0 | | | ||
| | |||
6 | SHARED VOTING POWER | | | |
4,000,000 shares of common stock (See Item 4) | | | ||
| | |||
7 | SOLE DISPOSITIVE POWER | | | |
0 | | | ||
| | |||
8 | SHARED DISPOSITIVE POWER | | | |
4,000,000 shares of common stock (See Item 4) | | | ||
| | |||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | |
4,000,000 shares of Common Stock (See Item 4) | | | ||
| | |||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | | | |
☐ | | | ||
| | |||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | |
11.4%1 (See Item 4) | | | ||
| | |||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | | | |
CO, HC | | | ||
| |
1 The percentage is calculated based upon 35,173,331 shares of the Issuer’s common stock outstanding as of January 31, 2020, as reported in the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on
February 14, 2020.
SCHEDULE 13G | |
CUSIP NO. None | Page 4 of 6 |
Item 1(a). | Name of Issuer: |
Transphorm, Inc., a Delaware corporation (“Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
75 Castilian Drive
Goleta, CA 93117
Item 2(a). | Name of Person Filing: |
This Schedule 13G is jointly filed by Nexperia B.V. (“Nexperia”) and Wingtech Technology Co. Ltd. (“Wingtech”, and together with Nexperia, the “Reporting Persons”).
The Reporting Persons have entered into a Joint Filing Agreement, dated February 25, 2020, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this
statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.
Item 2(b). | Address of Principal Business Office or, if None, Residence: |
The principal business address of Nexperia is Jonkerbosplein 52, 6534 AB Nijmegen, The Netherlands.
The principal business address of Wingtech is 4F-6F, Building 4 of Juxin Yuan, No. 188, Pingfu Road, Xuhui District, Shanghai, China.
Item 2(c). | Citizenship: |
Nexperia is a Dutch corporation.
Wingtech is a Chinese corporation.
Item 2(d). | Title of Class of Securities: |
Common stock, par value $0.0001
Item 2(e). | CUSIP Number: |
None
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
(a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
(b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
(c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
(d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
(e) | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). |
(f) | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F). |
(g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G). |
(h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). |
(i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). |
(j) | A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J). |
(k) | Group, in accordance with §240.13d-1(b)(1)(ii)(K). |
Not applicable.
Item 4. | Ownership. |
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) | Amount beneficially owned: |
See Item 9 of the attached cover pages.
SCHEDULE 13G | |
CUSIP NO. None | Page 5 of 6 |
(b) | Percent of class: See Item 11 of the attached cover pages. |
(c) | Number of shares as to which the person has: |
(i) | Sole power to vote or to direct the vote: Not applicable. |
(ii) | Shared power to vote or to direct the vote: See Item 6 of the attached cover pages. |
(iii) | Sole power to dispose or to direct the disposition of: Not applicable. |
(iv) | Shared power to dispose or to direct the disposition: See Item 8 of the attached cover pages. |
Wingtech owns 80% of the equity of Nexperia and may be deemed to share beneficial ownership of the shares of common stock of the Issuer of which Nexperia is the record owner.
The inclusion of the Reporting Persons and such securities in this report shall not be deemed an admission of beneficial ownership by the Reporting Persons for the purposes of Section 13(d) or 13(g) of the Act, or for
any other purposes.
Item 5. | Ownership of Five Percent or Less of a Class. |
Not applicable.
Item 6. | Ownership of More Than Five Percent on Behalf of Another Person. |
Not applicable.
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not applicable
Item 8. | Identification and Classification of Members of the Group. |
Not applicable.
Item 9. | Notice of Dissolution of Group. |
Not applicable.
Item 10. | Certifications. |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under
§240.14a-11.
SCHEDULE 13G | |
CUSIP NO. None | Page 6 of 6 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
Dated: | February 25, 2020 |
/s/ Charles Smit | |
By: Nexperia, B.V. | |
Name: Charles Smit | |
Title: SVP & General Counsel | |
/s/ Xuezheng Zhang | |
By: Wingtech Technology Co. Ltd. | |
Name: Xuezheng Zhang | |
Title: President |
SCHEDULE 13G |
Exhibit A
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including
amendments thereto) with respect to 4,000,000 shares of common stock of Transphorm, Inc. and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.
The undersigned further agree that each party hereto is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information
concerning such party contained therein; provided, however, that no party is responsible for the completeness or accuracy of the information concerning any other party making the filing, unless such party knows or has reason to believe that such
information is inaccurate.
IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement on February 25, 2020.
/s/ Charles Smit | |
By: Nexperia, B.V. | |
Name: Charles Smit | |
Title: SVP & General Counsel | |
/s/ Xuezheng Zhang | |
By: Wingtech Technology Co. Ltd. | |
Name: Xuezheng Zhang | |
Title: President |